Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Keywords: Chronic obstructive pulmonary lung respiratory disease efficacy placebo-controlled COPD FEV1 St Georges Respiratory Questionnaire
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 615
Healthy volunteers: no

Brief summary:
The primary objective is to evaluate the efficacy of AZD9668 compared with placebo in symptomatic COPD patients by assessing the effects on lung function and symptoms of COPD

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: AZD9668 intervention 2: Placebo
Intervention descriptions: intervention 1: 2 x 30 mg oral tablets bd for 12 weeks intervention 2: 2 x matched placebo to oral tablet bd for 12 weeks

Protocol document: